← Leaderboards
Hagop Kantarjian
University Of Texas Md Anderson Can Ctr
$4,345,422
Attributed
$4,345,422
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $4.3M · FY2008–19$5M$3.8M$2.5M$1.3M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$24,208,907 · 10
By mechanism
P50$20,217,031 · 8
P01$3,991,876 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Texas Md Anderson Can Ctr
Same institution · by research overlap
- Xifeng Wu$28,679,533
- Amr Soliman$8,984,631
- Margaret R Spitz$17,223,484
- Elizabeth L Travis$5,557,622
- Gabriel Lopez-Berestein$9,617,602
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchLaboratoriesResearch PersonnelLeukemiaTranslational ResearchBaseProgramsCareer DevelopmentMentorsClinicAreaCancer CenterClinical TrialsUniversity Of Texas M D Anderson Cancer CenterTexasUniversitiesNovel TherapeuticsDesignDrug ResistanceCareerSymposiumBasic ScienceEducational AspectsEpidemiologist
Grant awards (26)
Administrative Core$138,434
P50 · FY2019 · CA · contact PI
Career Enhancement Program$69,630
P50 · FY2019 · CA · contact PI
Administrative Core$95,951
P50 · FY2018 · CA · contact PI
Career Enhancement Program$20,190
P50 · FY2018 · CA · contact PI
SPORE University of Texas M.D. Anderson Cancer Center SPORE-Leukemia$2,300,000
P50 · FY2017 · CA · contact PI
Admin-Core-001$132,685
P50 · FY2017 · CA · contact PI
SPORE University of Texas M.D. Anderson Cancer Center SPORE-Leukemia$2,161,999
P50 · FY2016 · CA · contact PI
SPORE University of Texas M.D. Anderson Cancer Center SPORE-Leukemia$2,183,683
P50 · FY2015 · CA · contact PI
SPORE University of Texas M.D. Anderson Cancer Center SPORE-Leukemia$2,161,448
P50 · FY2014 · CA · contact PI
Administrative Core$2,161,448
P50 · FY2014 · CA · contact PI
SPORE University of Texas M.D. Anderson Cancer Center SPORE-Leukemia$2,150,500
P50 · FY2013 · CA · contact PI
Epigenetics and Epigenetic Therapy in AML$899,671
P50 · FY2013 · CA · contact PI
Administrative Core$102,484
P50 · FY2013 · CA · contact PI
Career Development Program$86,998
P50 · FY2013 · CA · contact PI
Career Development Program$74,475
P50 · FY2012 · CA · contact PI
Career Development Program$128,177
P50 · FY2011 · CA · contact PI
Career Development Program$126,199
P50 · FY2010 · CA · contact PI
New Approaches to the Biology and Treatment of Myelodysplastic Syndromes (MDS)$1,981,971
P01 · FY2009 · CA · contact PI
Career Development Program$137,114
P50 · FY2009 · CA · contact PI
New Approaches to the Biology and Treatment of Myelodysplastic Syndromes (MDS)$1,930,582
P01 · FY2008 · CA · contact PI
Career Development Program$92,643
P50 · FY2008 · CA · contact PI
University of Texas M.D. Anderson Cancer SPORE-Leukemia$2,493,302
P50 · FY2004 · CA
University of Texas M.D. Anderson Cancer SPORE-Leukemia$2,500,000
P50 · FY2003 · CA
COMBINED MODALITY THERAPY TO SUPPRESS PHILADELPHIA CHROMOSOME CELLS IN CML$0
P01 · FY2002 · CA
COMBINED MODALITY THERAPY TO SUPPRESS PHILADELPHIA CHROMOSOME CELLS IN CML$0
P01 · FY2001 · CA
COMBINED MODALITY THERAPY TO SUPPRESS PHILADELPHIA CHROMOSOME CELLS IN CML$79,323
P01 · FY2000 · CA